News Posts List
Tyrosine kinase expression profile in clear cell renal cell carcinoma
04/05/2012
To profile different tyrosine kinase (TK) expression patterns in clear cell renal carcinoma (ccRCC).
Why rapamycin causes diabetic-like symptoms in patients
04/05/2012
Scientists at Dana-Farber Cancer Institute have discovered why diabetic-like symptoms develop in some patients given rapamycin, an immune-suppressant drug that also has shown anti-cancer activity and may even slow ageing.
PRS-110 c-Met Antagonist Anticalin
04/05/2012
Pieris AG announced today the presentation of a range of in vitro and in vivo preclinical data for the company's proprietary c-Met antagonist program, PRS-110, at the American Association for Cancer Research (AACR) Annual Meeting, further establishing the compound as a differentiated next generation therapeutic protein.
Immune-Based Drug Combo Might Extend Cancer Survival
04/03/2012
Cancer patients who receive a combination of low-dose interleukin-2 and retinoic acid after conventional therapy seem to live longer than those who don't get the combination.
DNA Sequencing Lays Foundation for Personalized Cancer Treatment
04/02/2012
Scientists at Washington University School of Medicine in St. Louis are using powerful DNA sequencing technology not only to identify mutations at the root of a patient's tumor -- considered key to personalizing cancer treatment -- but to map the genetic evolution of disease and monitor response to treatment.
WilmsKids.com Offers Hope For Wilms Tumor Children
03/31/2012
We are building the world's largest community for families dealing with a child's encounter with Wilms tumor, a pediatric form of kidney cancer. All are welcome to join! This effort is supported by members of the International Kidney Cancer Congress (#IKCC on Twitter).
Kidney cancer subtype study finds low recurrence and cancer death rates
03/30/2012
Patients with papillary renal cell carcinoma, the second most common kidney cancer subtype, face a low risk of tumour recurrence and cancer-related death after surgery. Those are the key findings of a multi-centre study of nearly 600 patients published in the April issue of the urology journal BJUI.
One Drug to Shrink All Tumors?
03/30/2012
The treatment, an antibody that blocks a "do not eat" signal normally displayed on tumor cells, coaxes the immune system to destroy the cancer cells.
News Feed